Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Home
Aurobindo Pharma Ltd
Press Release Dec 28 2021
Business
Dec 28 2021
4 min read

Press Release Dec 28 2021

Aurobindo Pharma Limited has informed the Exchange regarding a press release dated December 28, 2021, titled "Aurobindo announces DCGI s permission to manufacture and market its generic version of Molnupiravir to be marketed as Molnaflu��, licensed from MSD and Ridgeback".

View Attachment